期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

二甲双胍治疗多囊卵巢综合征30例临床分析 被引量：2

原文传递
导出
摘要 选择PCOS患者30例。口服二甲双胍,500mg,每日3次,于餐后30min服,共6个月。测量患者体重并计算体重指数(BMI),测定患者血清卵泡刺激素(FSH)、黄体生成素(LH)、睾酮(T)、空腹血糖(FBG)及胰岛素(FBI)水平,计算空腹血糖与胰岛素的比值(GIR),并进行治疗前后的比较。结果用药后两组血胰岛素和雄激素水平均降低,胰岛素敏感指数上升,差异有显著性(P<0.01)。结论二甲双胍可有效地改善PCOS患者的胰岛素抵抗,降低血雄激素水平。
作者 谢作玲 孙子林
机构地区 江苏南京东南大学附属中大医院内分泌科
出处 《实用糖尿病杂志》 2009年第1期22-23,共2页 Journal of Practical Diabetology
关键词 二甲双胍 多囊卵巢综合征 胰岛素抵抗
分类号 R711.75 [医药卫生—妇产科学]
  • 相关文献

参考文献6

  • 1曹泽毅.中华妇产科学[M].北京：人民卫生出版社,1999.2129.
  • 2吴效科,苏延华,顾秋善.多囊卵巢综合征的高胰岛素血症及其分型的研究[J].生殖医学杂志,1994,3(2):80-83. 被引量：14
  • 3Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome asa form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion[J]. Endocr Rev 1995 ;16(3) :3222353.
  • 4Nestler J E J akubowicz DJ. Lean woman wit h polycystie ovary syndrome respond to insulin reduction wit h decreases in ovarian P450c17 αactivity and serum androgen[J]. J ClinEndocrinol Metab 1997 ;82(2) :4075 -4079.
  • 5Berker B, Emral R, Demirel C, et al. Increased insulin21ike growth factor2 I levels in women with polycystie ovary syndrome, and benericial effects of mefformin therapy [ J ]. Gynecol Endocrinol 2004 ; 19(3) :1252133.
  • 6李国华,黄薇.二甲双胍在多囊卵巢综合征的应用[J].实用妇产科杂志,2005,21(9):534-537. 被引量：34

二级参考文献17

  • 1Wu XK,Zhou SY,Sallinen,et al.Ovarian selective resistance to insulin signaling in the polycystic ovary syndrome.Fertil Steril,2003,80(4):954～965.
  • 2Karen ER,Evelyn OT,Jeanne VZ,et al.Evidence for competing effects of body mass,hyperinsulinemia,insulin resistance,and androgen on leptin levels among lean,overweight and obese women with polycystic syndrome.Fertil Steril,2002,78(3):479～486.
  • 3Macial GA,Soares JM,Alves El,et al.Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.Fertil Steril,2004,81(2):355～360.
  • 4Glueck CJ,Goldenberg N,Pranikoff J,et al.Height,weight,and motor-social development during the first 18 months of lifes in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy.Hum Reprod,2004,19(6):1323～1330.
  • 5Genazzani AD,Battaglia C,Malavasi B,et al.Metformin administration medolates and restore luteining hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome.Fetil Steril,2004,81(1):114～119.
  • 6Gleuck CJ,Wang P,Fontaine R,et al.Metformin to Restore Normal Menses in Oligo-Amenorrheic Teenage Girls With Polycystic Ovary Syndrome (PCOS).J Adol Health,2001,29(3):160～169.
  • 7Kolodziejczyk B,Duleba AJ,Spaczynski RZ,et al.Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.Fertil Steril,2000,73(6):1149～1154.
  • 8Laure C,Morin-Papunen,Ilkka V,et al.Endocrine and metabolic effect of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome:a randomized study.J.Clin.Endocrinol.Metab,2000,85(9):3161～3168.
  • 9Morin-Papunen L,Vauhkonen I,Koivunen R,et al.Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome:a randomized study.J Clin.Endocrinol.Metab,2003,88(1):148～156.
  • 10Elter K,Imir G,Durmusoglu F.Clinical,endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome:a randomized controlled study.Hum Reprod,2002,17(7):1729～1737.

共引文献3277

同被引文献5

引证文献2

实用糖尿病杂志
2009年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部